Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ABSK-043 by Abbisko Therapeutics for Solid Tumor: Likelihood of Approval
ABSK-043 is under clinical development by Abbisko Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
ABSK-043 by Abbisko Therapeutics for Melanoma: Likelihood of Approval
ABSK-043 is under clinical development by Abbisko Therapeutics and currently in Phase I for Melanoma. According to GlobalData, Phase I...
ABSK-043 by Abbisko Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
ABSK-043 is under clinical development by Abbisko Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...